Home › Companies › PACIRA BIOSCIENCES INC. › 2023-2024

PACIRA BIOSCIENCES INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and PACIRA BIOSCIENCES INC.’s Form 8-K, filed June 13, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.

6Ballot items
313Asset managers
2,072Fund votes
June 11, 2024Meeting date

Results at a glance

Meeting of June 11, 2024: 6 items on PACIRA BIOSCIENCES INC.’s Form 8-K, filed June 13, 2024: 6 without a stated outcome.

Material dissent

Elect Director: Laura Brege 49.9% of votes cast Outcome not stated Director under 80%
Elect Director: Mark Kronenfeld 75% of votes cast Outcome not stated Director under 80%

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore PACIRA BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by PACIRA BIOSCIENCES INC.

These tallies are PACIRA BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

PACIRA BIOSCIENCES INC. — official shareholder meeting results, meeting held June 11, 2024
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Laura Brege	20,659,043	--	--	20,779,899	2,676,760	49.9%	Not verified	—
Elect Director: Mark Froimson	40,275,000	--	--	1,163,942	2,676,760	97%	Not verified	—
Elect Director: Mark Kronenfeld	31,252,640	--	--	10,186,302	2,676,760	75%	Not verified	—
Elect Director: Michael Yang	40,666,349	--	--	772,593	2,676,760	98%	Not verified	—
2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024	43,901,001	204,074	10,627	--	--	99.5%	Not verified	—
3. Advisory vote to approve the compensation of the Company's named executive officers	37,228,983	4,087,635	122,324	--	2,676,760	90%	Not verified	—

Source: PACIRA BIOSCIENCES INC., Form 8-K, filed with the SEC on June 13, 2024 — read the filing on EDGAR.

How asset managers voted at the PACIRA BIOSCIENCES INC. 2023-2024 meeting

Each item below shows how the 313 asset managers that disclosed a PACIRA BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Laura Brege

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

49.9% Plurality election · of votes cast

FOR 49.9%WITHHELD

FOR: 20,659,043WITHHELD: 20,779,899

Details: description as filed, official tally, votes by 94 asset managers

Description as filed by funds: Election of Directors: Laura Brege

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Laura Brege”): 20,659,043 for, 20,779,899 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 49.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 94 asset managers below reported 10,346,987 for, 14,332,622 withheld, 161,569 abstained, 1,701 unknown.

FORWITHHOLD

FOR: 10,346,987ABSTAIN: 161,569WITHHOLD: 14,332,622UNKNOWN: 1,701

Largest asset managers voting on “Election of Directors: Laura Brege” at PACIRA BIOSCIENCES INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Vanguard	857,568	0	4,977,372	Mixed
BlackRock	0	0	5,376,254	Withhold
Pacer Funds Trust	1,620,024	0	0	For
Dimensional	1,405,769	0	0	For
Delaware/Macquarie	0	0	1,296,449	Withhold
Fidelity	963,759	0	34,110	For
Legg Mason	997,440	0	0	For
State Street	14,208	0	838,646	Withhold
JANUS INVESTMENT FUND	556,879	0	0	For
TIAA	406,000	0	0	For
Charles Schwab	396,013	0	0	For
Invesco	0	0	362,028	Withhold
DWS	0	0	344,696	Withhold
GLENMEDE FUND INC	330,214	0	0	For
IMPAX FUNDS SERIES TRUST I	260,027	0	0	For
Columbia Threadneedle	196,961	0	0	For
T. Rowe Price	0	0	194,586	Withhold
Aberdeen	192,189	0	0	For
Bridge Builder Trust	181,338	8,529	0	For
Jackson National	178,800	0	0	For
OLD WESTBURY FUNDS INC	174,821	0	0	For
Empower	35,057	0	119,034	Mixed
NICHOLAS Ltd EDITION, INC.	152,350	0	0	For
AMERICAN BEACON FUNDS	135,720	0	0	For
Nuveen	134,889	0	0	For

Showing the 25 largest of 94 asset managers. See all 94 in the interactive database.

2. Elect Director: Mark Froimson

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 40,275,000WITHHELD: 1,163,942

Details: description as filed, official tally, votes by 94 asset managers

Description as filed by funds: Election of Directors: Mark Froimson

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Mark Froimson”): 40,275,000 for, 1,163,942 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 94 asset managers below reported 24,511,662 for, 318,496 withheld, 11,020 abstained, 1,701 unknown.

FOR

FOR: 24,511,662ABSTAIN: 11,020WITHHOLD: 318,496UNKNOWN: 1,701

Largest asset managers voting on “Election of Directors: Mark Froimson” at PACIRA BIOSCIENCES INC., 2023-2024
Asset manager	For	Withheld	Vote
Vanguard	5,834,940	0	For
BlackRock	5,376,254	0	For
Pacer Funds Trust	1,620,024	0	For
Dimensional	1,405,769	0	For
Delaware/Macquarie	1,296,449	0	For
Fidelity	997,869	0	For
Legg Mason	997,440	0	For
State Street	851,515	1,339	For
JANUS INVESTMENT FUND	556,879	0	For
TIAA	406,000	0	For
Charles Schwab	396,013	0	For
Invesco	362,028	0	For
DWS	344,696	0	For
GLENMEDE FUND INC	330,214	0	For
IMPAX FUNDS SERIES TRUST I	260,027	0	For
Columbia Threadneedle	196,961	0	For
T. Rowe Price	0	194,586	Withhold
Aberdeen	192,189	0	For
Bridge Builder Trust	189,867	0	For
Jackson National	178,800	0	For
OLD WESTBURY FUNDS INC	174,821	0	For
Empower	154,091	0	For
NICHOLAS Ltd EDITION, INC.	152,350	0	For
AMERICAN BEACON FUNDS	135,720	0	For
Nuveen	134,889	0	For

Showing the 25 largest of 94 asset managers. See all 94 in the interactive database.

3. Elect Director: Mark Kronenfeld

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

75% Majority: yes · of votes cast

FOR 75%WITHHELD

FOR: 31,252,640WITHHELD: 10,186,302

Details: description as filed, official tally, votes by 94 asset managers

Description as filed by funds: Election of Directors: Mark Kronenfeld

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Mark Kronenfeld”): 31,252,640 for, 10,186,302 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 94 asset managers below reported 20,416,582 for, 4,251,856 withheld, 172,740 abstained, 1,701 unknown.

FORWITHHOLD

FOR: 20,416,582ABSTAIN: 172,740WITHHOLD: 4,251,856UNKNOWN: 1,701

Largest asset managers voting on “Election of Directors: Mark Kronenfeld” at PACIRA BIOSCIENCES INC., 2023-2024
Asset manager	For	Withheld	Vote
Vanguard	5,655,661	179,279	For
BlackRock	5,376,254	0	For
Pacer Funds Trust	1,620,024	0	For
Dimensional	1,405,769	0	For
Delaware/Macquarie	0	1,296,449	Withhold
Fidelity	997,869	0	For
Legg Mason	997,440	0	For
State Street	14,208	838,646	Withhold
JANUS INVESTMENT FUND	556,879	0	For
TIAA	406,000	0	For
Charles Schwab	0	396,013	Withhold
Invesco	0	362,028	Withhold
DWS	344,696	0	For
GLENMEDE FUND INC	330,214	0	For
IMPAX FUNDS SERIES TRUST I	0	260,027	Withhold
Columbia Threadneedle	196,961	0	For
T. Rowe Price	0	194,586	Withhold
Aberdeen	192,189	0	For
Bridge Builder Trust	189,867	0	For
Jackson National	178,800	0	For
OLD WESTBURY FUNDS INC	174,821	0	For
Empower	0	154,091	Withhold
NICHOLAS Ltd EDITION, INC.	152,350	0	For
AMERICAN BEACON FUNDS	135,720	0	For
Nuveen	134,889	0	For

Showing the 25 largest of 94 asset managers. See all 94 in the interactive database.

4. Elect Director: Michael Yang

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 40,666,349WITHHELD: 772,593

Details: description as filed, official tally, votes by 94 asset managers

Description as filed by funds: Election of Directors: Michael Yang

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Michael Yang”): 40,666,349 for, 772,593 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 94 asset managers below reported 24,820,067 for, 10,091 withheld, 11,020 abstained, 1,701 unknown.

FOR

FOR: 24,820,067ABSTAIN: 11,020WITHHOLD: 10,091UNKNOWN: 1,701

Largest asset managers voting on “Election of Directors: Michael Yang” at PACIRA BIOSCIENCES INC., 2023-2024
Asset manager	For	Vote
Vanguard	5,834,940	For
BlackRock	5,376,254	For
Pacer Funds Trust	1,620,024	For
Dimensional	1,405,769	For
Delaware/Macquarie	1,296,449	For
Fidelity	997,869	For
Legg Mason	997,440	For
State Street	852,854	For
JANUS INVESTMENT FUND	556,879	For
TIAA	406,000	For
Charles Schwab	396,013	For
Invesco	362,028	For
DWS	344,696	For
GLENMEDE FUND INC	330,214	For
IMPAX FUNDS SERIES TRUST I	260,027	For
Columbia Threadneedle	196,961	For
T. Rowe Price	194,586	For
Aberdeen	192,189	For
Bridge Builder Trust	189,867	For
Jackson National	178,800	For
OLD WESTBURY FUNDS INC	174,821	For
Empower	154,091	For
NICHOLAS Ltd EDITION, INC.	152,350	For
AMERICAN BEACON FUNDS	135,720	For
Nuveen	134,889	For

Showing the 25 largest of 94 asset managers. See all 94 in the interactive database.

5. 3. Advisory vote to approve the compensation of the Company's named executive officers

Outcome not verified Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 10 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%

FOR: 37,228,983AGAINST: 4,087,635

Details: description as filed, official tally, votes by 312 asset managers

Description as filed by funds: Approval, on an advisory basis, of the compensation of our named executive officers.

PACIRA BIOSCIENCES INC.’s own tally for this item (“3. Advisory vote to approve the compensation of the Company's named executive officers”): 37,228,983 for, 4,087,635 against, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 99 asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers.” at PACIRA BIOSCIENCES INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	5,834,940	0	For
BlackRock	5,376,254	0	For
Pacer Funds Trust	1,620,024	0	For
Dimensional	1,405,769	0	For
Delaware/Macquarie	1,296,449	0	For
Fidelity	997,869	0	For
Legg Mason	997,440	0	For
State Street	852,854	0	For
JANUS INVESTMENT FUND	556,879	0	For
TIAA	406,000	0	For
Charles Schwab	396,013	0	For
Invesco	362,028	0	For
DWS	344,696	0	For
GLENMEDE FUND INC	330,214	0	For
IMPAX FUNDS SERIES TRUST I	260,027	0	For
Columbia Threadneedle	196,961	0	For
T. Rowe Price	194,586	0	For
Aberdeen	0	192,189	Against
Bridge Builder Trust	189,867	0	For
Jackson National	178,800	0	For
OLD WESTBURY FUNDS INC	174,821	0	For
Tributary Funds, Inc.	163,535	0	For
Empower	154,091	0	For
NICHOLAS Ltd EDITION, INC.	152,350	0	For
AMERICAN BEACON FUNDS	135,720	0	For

Fund voting reports, all 99 managers: 24,811,636 for, 319,894 against, 4,474 abstained, 1,701 unknown. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 236 asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers.” at PACIRA BIOSCIENCES INC., 2023-2024
Asset manager	For	Against	Vote
State Street	1,741,441	0	For
BlackRock	1,728,777	416	For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST	1,418,391	0	For
Clearbridge Investments, LLC	1,171,977	0	For
Stephens Investment Management Group LLC	1,090,838	0	For
GEODE CAPITAL MANAGEMENT, LLC	1,023,600	0	For
Rock Springs Capital Management LP	976,276	0	For
FRONTIER CAPITAL MANAGEMENT CO LLC	933,070	30,037	For
RICE HALL JAMES & ASSOCIATES, LLC	14,415	724,563	Against
Janus Henderson	578,741	0	For
BAILLIE GIFFORD & CO LTD	0	576,803	Against
SCHRODER INVESTMENT MANAGEMENT GROUP	0	576,121	Against
Nuveen	566,615	0	For
Aberdeen	0	523,545	Against
Northern Trust	469,282	30	For
Charles Schwab	416,932	0	For
Archon Capital Management LLC	0	0	--
Invesco	380,990	0	For
MELLON INVESTMENTS Corp	373,261	0	For
Loomis Sayles	348,806	0	For
ARDSLEY ADVISORY PARTNERS LP	331,712	0	For
T. Rowe Price	310,271	0	For
PRINCIPAL GLOBAL INVESTORS	264,193	0	For
Tributary Capital Management, LLC	233,755	0	For
Wellington	229,703	0	For

Institutional-manager reports, all 236 managers: 18,090,228 for, 3,067,527 against, 2,114 abstained, 7,558 not voted, 395,035 unknown. Showing the 25 largest; see all in the interactive database.

6. 2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Combines 7 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%

FOR: 43,901,001AGAINST: 204,074

Details: description as filed, official tally, votes by 102 asset managers

Description as filed by funds: Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.

PACIRA BIOSCIENCES INC.’s own tally for this item (“2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 43,901,001 for, 204,074 against, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 102 asset managers below reported 25,173,323 for, 652 against, 4,474 abstained, 1,701 unknown.

FOR

FOR: 25,173,323AGAINST: 652ABSTAIN: 4,474UNKNOWN: 1,701

Largest asset managers voting on “Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fisca” at PACIRA BIOSCIENCES INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	5,834,940	0	For
BlackRock	5,376,254	0	For
Pacer Funds Trust	1,620,024	0	For
Dimensional	1,405,769	0	For
Delaware/Macquarie	1,296,449	0	For
Fidelity	997,869	0	For
Legg Mason	997,440	0	For
State Street	852,202	652	For
JANUS INVESTMENT FUND	556,879	0	For
TIAA	406,000	0	For
Charles Schwab	396,013	0	For
Invesco	362,028	0	For
DWS	344,696	0	For
GLENMEDE FUND INC	330,214	0	For
IMPAX FUNDS SERIES TRUST I	260,027	0	For
Columbia Threadneedle	196,961	0	For
T. Rowe Price	194,586	0	For
Aberdeen	192,189	0	For
Bridge Builder Trust	189,867	0	For
Jackson National	178,800	0	For
OLD WESTBURY FUNDS INC	174,821	0	For
Tributary Funds, Inc.	163,535	0	For
Empower	154,091	0	For
NICHOLAS Ltd EDITION, INC.	152,350	0	For
AMERICAN BEACON FUNDS	135,720	0	For

Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.

Largest PACIRA BIOSCIENCES INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 46,517,410 shares outstanding at the time of that meeting.

Fund voting reports: top PACIRA BIOSCIENCES INC. shareholders by shares voted on “Ratification of the appointment of KPMG LLP as our independent registered public accounting…”, 2023-2024
#	Asset manager	% of shares outstanding
1	Vanguard	12.54%
2	BlackRock	11.56%
3	Pacer Funds Trust	3.48%
4	Dimensional	3.02%
5	Delaware/Macquarie	2.79%
6	Fidelity	2.15%
7	Legg Mason	2.14%
8	State Street	1.83%
9	JANUS INVESTMENT FUND	1.20%
10	TIAA	0.87%

Institutional-manager reports: top PACIRA BIOSCIENCES INC. shareholders by shares voted on “Approval, on an advisory basis, of the compensation of our named executive officers.”, 2023-2024
#	Asset manager	% of shares outstanding
1	State Street	3.74%
2	BlackRock	3.72%
3	MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST	3.05%
4	Clearbridge Investments, LLC	2.52%
5	Stephens Investment Management Group LLC	2.35%
6	GEODE CAPITAL MANAGEMENT, LLC	2.20%
7	Rock Springs Capital Management LP	2.10%
8	FRONTIER CAPITAL MANAGEMENT CO LLC	2.07%
9	RICE HALL JAMES & ASSOCIATES, LLC	1.59%
10	Janus Henderson	1.24%

Reported PACIRA BIOSCIENCES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

PACIRA BIOSCIENCES INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
BlackRock	15.77%	13F
Vanguard Group	11.17%	13F
State Street	4.09%	13F
Renaissance Technologies	4.05%	13F
Dimensional Fund Advisors	3.50%	13F
Goldman Sachs	2.82%	13F
Morgan Stanley	2.46%	13F
Geode Capital	2.23%	13F
Nuveen	1.22%	13F
Invesco	1.18%	13F

Percentages above are of 46,517,410 shares outstanding, as reported by PACIRA BIOSCIENCES INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PACIRA BIOSCIENCES INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At PACIRA BIOSCIENCES INC.'s shareholder meeting held June 11, 2024, in the 2023-2024 proxy season, 313 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 2,072 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of our named executive officers. — FOR was 90% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: PACIRA BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2024.

PACIRA BIOSCIENCES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.